For the children who live in Sahel and sub-Sahel regions of Africa, the rainy season produces a seasonal surge in sickness and death from malaria. Since 2012, the World Health Organization has recommended Seasonal Malaria Chemoprevention (SMC)* as an effective tool to prevent malaria in children under five during the rainy season.

Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) is the first project of its kind promoting the scale-up of SMC. Thanks to ACCESS-SMC, a Unitaid-funded project led by Malaria Consortium in partnership with Catholic Relief Services, SMC treatments has been provided to over 6,3 million vulnerable children in seven West African countries.

Objectives :

1.     Foster country and community ownership.

2.     Reduce risks of misunderstanding and negative perceptions.

3.     Ensure adherence to SMC dose completion.